Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  85 results for ""OMALIZUMAB""

Your Filters

Geographic : italy
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

A multicenter approach to evaluate omalizumab effectiveness in Samter's triad.

  • Authors : Cameli P; Respiratory Diseases Unit, Department of Medical and Surgical Sciences and Neurosciences, University of Siena. .; D'Alessandro M

Subjects: Aspirin/Aspirin/Aspirin/*adverse effects ; Asthma/Asthma/Asthma/*drug therapy ; Asthma, Aspirin-Induced/Asthma, Aspirin-Induced/Asthma, Aspirin-Induced/*drug therapy

  • Source: Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace [Monaldi Arch Chest Dis] 2020 Aug 06; Vol. 90 (3). Date of Electronic Publication: 2020 Aug 06.Publisher: Fondazione clinica del lavoro edizioni : Distributed by PI-ME tipographia Country of Publication: Italy NLM ID: 9307314

Record details

Read More Add to Saved list
×
Academic Journal

Omalizumab for chronic spontaneous urticaria in "complex" patients: data from real-life clinical practice.

  • Authors : Vollono L; Dermatology Department, University of Rome, Tor Vergata, Italy.; Piccolo A

Subjects: Anti-Allergic Agents/Anti-Allergic Agents/Anti-Allergic Agents/*therapeutic use ; Chronic Urticaria/Chronic Urticaria/Chronic Urticaria/*drug therapy ; Omalizumab/Omalizumab/Omalizumab/*therapeutic use

  • Source: Drug design, development and therapy [Drug Des Devel Ther] 2019 Sep 06; Vol. 13, pp. 3181-3186. Date of Electronic Publication: 2019 Sep 06 (Print Publication: 2019).Publisher: Dove Press Limited Country of Publication: New Zealand NLM ID: 101475745 Publication Model: eCollection Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Switching from omalizumab to mepolizumab: real-life experience from Southern Italy.

  • Authors : Carpagnano GE; Department of Basic Medical Sciences, Neuroscience and Sense Organs, Section of Respiratory Disease, University 'Aldo Moro' of Bari, Bari, Italy.; Pelaia C

Subjects: Drug Substitution*/Drug Substitution*/Drug Substitution*/adverse effects; Anti-Allergic Agents/Anti-Allergic Agents/Anti-Allergic Agents/*therapeutic use ; Anti-Asthmatic Agents/Anti-Asthmatic Agents/Anti-Asthmatic Agents/*therapeutic use

  • Source: Therapeutic advances in respiratory disease [Ther Adv Respir Dis] 2020 Jan-Dec; Vol. 14, pp. 1753466620929231.Publisher: SAGE Publications Country of Publication: England NLM ID: 101316317 Publication Model: Print Cited Medium: Internet ISSN: 1753-4666

Record details

Read More Add to Saved list
×
Academic Journal

Omalizumab in Chronic Urticaria: An Italian Survey.

  • Authors : Damiani G; Young Dermatologists Italian Network (YDIN), GISED, Bergamo, Italy, .; Clinical Dermatology, IRCCS Istituto Ortopedico Galeazzi, Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy, .

Subjects: Anti-Allergic Agents/Anti-Allergic Agents/Anti-Allergic Agents/*therapeutic use ; Omalizumab/Omalizumab/Omalizumab/*therapeutic use ; Urticaria/Urticaria/Urticaria/*drug therapy

  • Source: International archives of allergy and immunology [Int Arch Allergy Immunol] 2019; Vol. 178 (1), pp. 45-49. Date of Electronic Publication: 2018 Nov 05.Publisher: S. Karger Country of Publication: Switzerland NLM ID: 9211652 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study.

  • Authors : Pelaia C; Department of Medical and Surgical Sciences, Section of Respiratory Diseases, University 'Magna Græcia' of Catanzaro, Italy.; Calabrese C

Subjects: Anti-Asthmatic Agents/Anti-Asthmatic Agents/Anti-Asthmatic Agents/*therapeutic use ; Asthma/Asthma/Asthma/*drug therapy ; Eosinophils/Eosinophils/Eosinophils/*metabolism

  • Source: Pulmonary pharmacology & therapeutics [Pulm Pharmacol Ther] 2019 Feb; Vol. 54, pp. 25-30. Date of Electronic Publication: 2018 Nov 07.Publisher: Academic Press Country of Publication: England NLM ID: 9715279 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients.

  • Authors : Marzano AV; UOC Dermatologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Università degli Studi di Milano, Milan, Italy.

Subjects: Anti-Allergic Agents/Anti-Allergic Agents/Anti-Allergic Agents/*therapeutic use ; Omalizumab/Omalizumab/Omalizumab/*therapeutic use ; Urticaria/Urticaria/Urticaria/*drug therapy

  • Source: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2019 May; Vol. 33 (5), pp. 918-924. Date of Electronic Publication: 2018 Dec Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9216037 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Asthma control in severe asthmatics under treatment with omalizumab: a cross-sectional observational study in Italy.

Subjects: Anti-Asthmatic Agents/Anti-Asthmatic Agents/Anti-Asthmatic Agents/*therapeutic use ; Asthma/Asthma/Asthma/*drug therapy ; Omalizumab/Omalizumab/Omalizumab/*therapeutic use

  • Source: Pulmonary pharmacology & therapeutics [Pulm Pharmacol Ther] 2015 Apr; Vol. 31, pp. 123-9. Date of Electronic Publication: 2014 Sep 30.Publisher: Academic Press Country of Publication: England NLM ID: 9715279 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Omalizumab management beyond clinical trials: the added value of a network model.

Subjects: Cooperative Behavior*; Anti-Asthmatic Agents/Anti-Asthmatic Agents/Anti-Asthmatic Agents/*therapeutic use ; Asthma/Asthma/Asthma/*drug therapy

  • Source: Pulmonary pharmacology & therapeutics [Pulm Pharmacol Ther] 2014 Oct; Vol. 29 (1), pp. 74-9. Date of Electronic Publication: 2014 Feb 06.Publisher: Academic Press Country of Publication: England NLM ID: 9715279 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Pediatric asthma control during the COVID-19 pandemic.

  • Authors : Ferraro VA; Department of Women's and Children's Health, University of Padova, Padova, Italy.; Zamunaro A

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Pandemics*

  • Source: Immunity, inflammation and disease [Immun Inflamm Dis] 2021 Jun; Vol. 9 (2), pp. 561-568. Date of Electronic Publication: 2021 Mar 03.Publisher: John Wiley and Sons Ltd Country of Publication: England NLM ID: 101635460 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Effectiveness of omalizumab in patients with severe allergic asthma with and without chronic rhinosinusitis with nasal polyps: a PROXIMA study post hoc analysis.

Subjects: NASAL polyps; ASTHMA; SINUSITISITALY

  • Source: Clinical & Translational Allergy; 6/26/2020, Vol. 10 Issue 1, p1-9, 9p

Record details

Read More Add to Saved list
×
  • 1-10 of  85 results for ""OMALIZUMAB""